UK: The NHS Are Testing a Cannabis Product for the First Time

Warning message

The subscription service is currently unavailable. Please try again later.

The makers of the MediPen vaporiser are confident that by setting a precedent for testing cannabis products with this reputable body, it will have a huge impact on the public’s perception of cannabis.

A cannabidiol (CBD) vaporiser that has helped thousands of people suffering from a variety of conditions is being tested by an NHS unit, an unprecedented step that could increase scrutiny on cannabis’ medical benefits and have a huge impact on the UK’s draconian legislation on it.

The MediPen, a completely legal way to consume CBD, which, unlike tetrahydrocannabinol (THC), is completely non-psychoactive, has been on sale for a year now and drew very positive reviews, relieving the pain of people with everything from depression and anxiety to arthritis and fibromyalgia.

The company told The Independent it has been consulting with a group of production and regulatory support pharmacists from the NHS for the past few months, who have been testing their proprietary...

e-mail icon Facebook icon Twitter icon LinkedIn icon Reddit icon
Rate this article: 

This marijuana news is brought to you by 420 Intel. For the latest breaking cannabis industry news, subscribe to the 420 Intel newsletter. If you'd like to promote your product or service in this area after every article, contact us.